Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Hormones significantly affect hair growth and loss, with potential for new treatments.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Premature hair graying is common and linked to stress, obesity, vitamin deficiencies, family history, lack of exercise, smoking, and allergies.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Dhatryadi Rasayana, an Ayurvedic herbal mix, may be a safe and effective way to prevent premature hair greying.

Pollution increases a compound in the skin that can lead to faster aging and more inflammation.

Autophagy prevents early aging and maintains lipid and pheromone balance in mouse glands.

Premature hair graying is caused by genetics, stress, and lifestyle, and affects mental health.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Activating Nrf2 can help protect against hearing loss.

Extracts from Alnus sibirica and oregonin may help with hair growth and prevent hair loss.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Over half of young people in Saudi Arabia experience early gray hair, linked to factors like smoking, stress, and family history.

Hair loss causes stress and affects mental health; treatment and support needed.

BCC can protect heart cells from damage caused by oxidative stress.